Recipient
Resilience Biotechnologies Inc.Department
UnknownAmount
$2.1M
Province
ONType
C
Agreement Number
959304
Purpose
The purpose of the funding will be to support a feasibility assessment and detailed engineering design for the expansion of Therapure’s current mammalian cell culture (MCC) capacity in support of VBI’s coronavirus vaccine as well as other MCC projects and coronavirus vaccines that require insect cell/baculovirus expression systems and potentially adeno viral vectors. The two areas at Therapure’s current biomanufacturing facility that will be assessed to support pandemic vaccine manufacturing:
Resilience Biotechnologies Inc. × Unknown
2 grants totalling $4.2M
Industrial Research Assistance Program – Contributions to Firms
1,000 grants totalling $111.3M
Related Grants
| Recipient | Amount | Program |
|---|---|---|
| Laurent Thérapeutiques | $7.0M | Industrial Research Assistance Program –... |
| Laurent Thérapeutiques | $7.0M | Industrial Research Assistance Program –... |
| Laurent Thérapeutiques | $7.0M | Industrial Research Assistance Program –... |
| Introhive Services Inc. | $6.7M | Industrial Research Assistance Program –... |
| Avidbots Corp. | $6.0M | Industrial Research Assistance Program –... |